Abstract
Until recently, children and adolescents were not eligible for COVID-19 vaccination. They may have been a considerable source of SARS-CoV-2 spread. We evaluated SARS-CoV-2 IgG antibody seroprevalence in Israeli children aged 0-15 years from January 2020 to March 2021. Seropositivity was 1.8-5.5 times higher than COVID-19 incidence rates based on PCR testing. We found that SARS-CoV-2 infection among children is more prevalent than previously thought and emphasise the importance of seroprevalence studies to accurately estimate exposure.
| Original language | English |
|---|---|
| Article number | 2101040 |
| Journal | Eurosurveillance |
| Volume | 26 |
| Issue number | 48 |
| DOIs | |
| State | Published - 2 Dec 2021 |
Bibliographical note
Publisher Copyright:© 2021 European Centre for Disease Prevention and Control (ECDC). All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Epidemiology
- Public Health, Environmental and Occupational Health
- Virology
Fingerprint
Dive into the research topics of 'Under-diagnosis of SARS-CoV-2 infections among children aged 0-15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver